Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Use of High-Temperature Superconductors to Make MR Imaging More Affordable, Accessible and Sustainable

By MedImaging International staff writers
Posted on 07 Dec 2022

A new research partnership focuses on the use of high-temperature superconductors to make MR imaging more affordable, accessible and sustainable in the future. Operating at higher temperatures and eliminating the use of liquid helium during both production and operation could reduce the size, weight and cost of MRI scanners, increasing accessibility across all patient communities and bringing advanced diagnostic imaging closer to a first line diagnostic tool.

Royal Philips (Amsterdam‎, Noord-Holland) has entered into a research partnership with magnet solutions provider MagCorp (Tallahassee, FL, USA) to explore superconducting magnets for MR scanners that do not require cooling to ultra-low temperatures (-452 °F or -269 °C) using liquid helium. Developing more sustainable alternatives to helium-cooled MRI magnets at a lower cost has the potential to offer significant benefits by making advanced MR imaging available to more patients in more diverse settings as well as potentially reducing radiology department capital and operating costs.

Operating at higher temperatures closer to ambient room temperature and eliminating liquid helium from both the production and operation of MRI scanners provides two major advantages. First, it decreases energy consumption required to sustain operation and reduces dependence on a finite and increasingly scarce natural resource, produced largely as a by-product of fossil-fuel (natural gas) extraction. Conventional MRI scanners often vent helium, which once released into the atmosphere escapes into outer space never to be seen again. Second, and just as important, it has the potential to reduce the size, weight and costs of MRI scanners. As a result, MRI’s superior diagnostic and functional imaging capabilities – notably its excellent soft-tissue imaging and absence of ionizing X-ray radiation – could be enjoyed by a larger number of patients, expanding access into underserved communities. The partnership between Philips and MagCorp aims to help realize these two major advantages.

With the introduction of its BlueSeal magnet technology in 2018, Philips already has a commercially available non-venting MRI scanner in widespread use that once charged with a small amount of helium (7 liters instead of a conventional scanner’s 1,500 liters) are sealed and operate without requiring additional helium for their entire operational life. Clinical MRI scanners that completely eliminate the need for helium are a clear direction for innovation in the long term. Using high-temperature superconductors supports a complete shift towards helium independence. The research partnership will focus on characterizing and demonstrating the feasibility of appropriate superconducting materials capable of operating at higher temperatures than today’s niobium-based superconductors. In common with helium, niobium is also a scarce element, whereas some of the new materials being investigated by the research team are based on more abundant elements. In addition to basic materials research, the team will also investigate the steps needed to commercialize the materials, and the technologies needed to enable their use in future MRI scanners.

“Florida State University’s MagLab, part of the U.S. National High Magnetic Field Laboratory, is home to many of the world’s leading researchers on novel superconducting materials that don’t require liquid helium temperatures to operate. Philips has decades of MR scanner design and development experience, including most recently the launch of the BlueSeal magnet technology,” said Josh Hilderbrand, Director, Head of MRI Magnet Research and Development at Philips. “Combining these resources with MagCorp’s research facilitation services will help leverage the latest technology to accelerate access and availability of MRI to more patients and healthcare providers.”

“MagCorp is proud of this partnership, which brings together Philips' game-changing BlueSeal magnet technology and the FSU MagLab’s unrivaled knowledge base about superconductors that can operate in a helium-free environment," said Jeff Whalen, Director of MagCorp. "Combining Philips' forward-thinking approach with FSU MagLab's scientists, who have a wealth of relevant expertise in the application of new superconductors, means Philips will be in the best position to develop innovations around this technology."

Related Links:
Royal Philips
MagCorp

Gold Member
X-Ray QA Meter
T3 AD Pro
1.5T Superconducting MRI System
uMR 680
New
Portable Color Doppler Ultrasound Scanner
DCU10
Endoscopic Ultrasound Fine Needle Biopsy Device
Acquire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: CHEST has released a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration specimen processing and handling (Photo courtesy of CHEST)

New Guideline on Handling Endobronchial Ultrasound Transbronchial Needle Samples

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard procedure for the initial diagnosis and staging of lung cancer; however, there is limited guidance on... Read more

Nuclear Medicine

view channel
Image: PET/CT scans of a patient with suspected insulinoma and a cross-sectional view of the torso (Photo courtesy of J. Nucl. Med.; doi.org/10.2967/jnumed.124.268158)

PET Scan Based on Lizard Saliva Reliably Detects Benign Tumors in Pancreas

The pancreas contains cells known as beta cells that produce insulin. Insulin is a hormone that assists the body in absorbing sugar from the bloodstream and storing it in areas such as muscle cells, helping... Read more

General/Advanced Imaging

view channel
Image: Heavy smokers can ben Image (2):	efit from lung cancer screening using low-dose CT (Photo courtesy of 123RF)

Low-Dose CT Screening for Lung Cancer Can Benefit Heavy Smokers

Lung cancer is often diagnosed at a late stage, with only about one-fifth to one-sixth of patients surviving five years after diagnosis. A new report now suggests that low-dose computed tomography (CT)... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The partnership will focus on integrating the Siemens Multitom Rax imaging system into the Medtronic AiBLE ecosystem for spine surgery (Photo courtesy of Siemens Healthineers)

Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies

A new global partnership aims to explore opportunities to further expand access to advanced pre-and post-operative imaging technologies for spine care. Medtronic plc (Galway, Ireland) and Siemens Healthineers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.